Hyperthyroidism in molar pregnancy: β-HCG levels do not always reflect severity

Area of Science:

• Endocrinology
• Gynecology
• Oncology

Background:

• Molar pregnancy involves abnormal trophoblastic cell proliferation, leading to elevated human chorionic gonadotrophin (hCG) levels.
• Elevated hCG can cause secondary hyperthyroidism due to structural similarity with thyroid-stimulating hormone (TSH).

Purpose of the Study:

• To investigate the relationship between beta-human chorionic gonadotrophin (β-hCG) levels and disease severity in gestational trophoblastic disease (GTD).

Main Methods:

• Case study of two patients presenting with vaginal bleeding and abdominal pain.
• Diagnostic procedures included ultrasound, β-hCG measurement, and thyroid function tests.

Main Results:

• Both patients diagnosed with GTD and hyperthyroidism based on elevated β-hCG and thyroid function tests.
• Despite lower β-hCG, one patient experienced a severe thyroid storm, while the other with higher β-hCG remained stable.

Conclusions:

• Beta-human chorionic gonadotrophin (β-hCG) levels may not consistently correlate with the clinical severity or patient prognosis in gestational trophoblastic disease (GTD).